, Abstract-Background: Patients who are resuscitated with naloxone frequently refuse a period of observation, even though they may be suffering from a variety of medical and psychiatric comorbidities. Emergency physicians (EPs) are then confronted with the challenge of how best to serve patients' interests while respecting autonomy. Objectives: We sought to characterize how EPs think about this kind of dilemma and the strategies they use to resolve them. Methods: We conducted qualitative semi-structured interviews with a convenience sample of 59 emergency physicians attending the American College of Emergency Physicians' Scientific Assembly in October 2018. Three case vignettes highlighting different clinical and ethical features served as prompts. Interviews were analyzed using a constant comparative method to identify patterns of responses and derive key themes. Results: Across the vignettes, EPs demonstrated diverse approaches to observation, assessing decision-making capacity and encouraging compliance. Some EPs refused to comply with a patient's wishes even when they had determined a patient demonstrated capacity. Conversely, a few EPs were willing to allow patients to leave the emergency department (ED) without assessing capacity, or despite determining that the patient lacked capacity. Common reasons for complying with patients' demands were concerns about the patients' rights and concerns about the safety of staff. Most physicians interviewed reported no institutional guidelines or education on the topic, and many physicians expressed an interest in providing medication for addiction treatment in the ED. Conclusions: EPs approach this clinical and ethical dilemma in widely divergent ways. Consensus about strategies for navigating patients' wishes relative to clinical concerns are needed to help EPs manage these challenging cases. 
INTRODUCTION
The number of patients transported to emergency departments (EDs) after resuscitation with naloxone following an opioid overdose remains at epidemic proportions, with 142,000 opioid-related ED visits in the United States from 2016 through 2017, and an estimated 100,734 ED visits in 2017-2108 from heroin alone, with noted increases in urban areas and the Midwest (1, 2) . Patients who have been resuscitated with naloxone may wish to refuse the period of observation commonly RECEIVED: 19 May 2019; FINAL SUBMISSION RECEIVED: 3 September 2019; ACCEPTED: 13 September 2019 recommended to monitor for rebound apnea and other symptoms. This conflict between medical recommendations and patient preferences is exacerbated because patients in this situation may be under the continued influence of opioids or other substances, already withdrawing from opioids, or suffering from comorbid conditions.
This conflict is compounded by differing recommendations about how long patients should be observed to prevent rebound apnea. Even in the simplest case of a patient who had been administered naloxone for a shortacting opioid, recommendations by influential sources include observing patients for 1 h if patients meet certain parameters, 1-2 h, 4 h, and ''at least several hours'' (3) (4) (5) (6) . Adding to these conflicting recommendations are concerns that fentanyl derivatives or novel synthetic opioids that have more recently entered the street supply of opioids may require larger doses of naloxone or prolonged periods of observation (7) (8) (9) . Some clarity is beginning to emerge that patients meeting defined clinical parameters may be discharged safely 1 h after naloxone administration (3, 10, 11) . However, the differing composition, potency, and half-lives of the opioids used by patients, as well as the potential presence of co-ingestants, make it difficult to define a standard ''safe'' duration of observation for rebound apnea for patients outside those parameters.
Importance
Refusal of observation after naloxone resuscitation is common, difficult to navigate, and little discussed in medical ethics literature. Emergency physicians (EPs) are confronted with the challenge of balancing patient autonomy with clinical risks that can be substantial but hard to quantify precisely. While patients have a fundamental ethical and legal right to refuse care, exercise of this right requires decision-making capacity, which cravings and symptoms of withdrawal might compromise (12) (13) (14) (15) (16) (17) (18) (19) . Conversely, physicians may think that it is in a patient's best interest to remain under observation, but that the potential for escalation inherent to ensuring compliance, particularly in under-resourced EDs, may lead physicians to acquiesce to patient demands to leave, despite substantial risks or even clearly impaired decision-making capacity (20) .
Goals of This Investigation
We sought to characterize EP practice in treating and observing patients who received naloxone for opioid overdoses, and to understand the clinical and ethical rationales for their practice. We conducted qualitative interviews with EPs to help explore factors that might influence their practice, as well as the effects of experience, practice settings, and legal and institutional guidelines.
MATERIALS AND METHODS

Study Design
We conducted a series of open-ended, semi-structured interviews with a convenience sample of EPs. We used qualitative methods to elicit the perspective and concerns of physicians who deal with opioid overdoses frequently. Open-ended questions were combined with three case prompts that were designed to elicit a range of responses from interviewees and examine the extent to which clinical and socioeconomic factors might further influence decision-making with patients who do not wish to remain for observation after receiving naloxone. This study was intended to help illustrate the dimensions of the ethical dilemmas considered by EPs, and the range of strategies that physicians use to help balance clinical and ethical concerns. As a qualitative study, we did not recruit a statistically representative sample of physicians, but instead attempted to recruit as wide a range of perspectives as possible.
Interviews were structured around a guide, with two sections (Appendix A). The first section asked about participants' typical practice in treating and observing patients with opioid overdoses, what evidence they used to establish their current practice, if their institution provided specific guidelines on observation after naloxone, and if they received education from their institution on the topic. The second used three cases as interview prompts in which patients presented to the ED after receiving naloxone in the prehospital setting. The cases were designed to examine practice and decision-making across several domains: the likely opioid or opioids used by the patient and their relevant half-lives; the patient's prior drug use, age, sex, and socioeconomic status; and the resource availability of the ED setting. The first case featured a young woman who is a reported firsttime user of i.v. opioids, the second a middle-aged man with an established history of multiple substance use disorders (SUDs) and prior visits for i.v. fentanyl use, and the third is an older man with multiple prescriptions for long-acting oral opioids. The patients in all three cases refused further observation immediately after arrival. The cases were designed to reflect an increasing risk of harm from the opioid overdose, with an additional question at the end of the final case added to assess whether concerns for intentional overdose or suicidal ideation changed management. Interview probe questions were designed specifically to elicit EPs' standards of decision-making capacity.
The study was approved by the Institutional Review Boards of Beth Israel Deaconess Medical Center, Kansas University Medical Center, and the Medical College of Wisconsin. We used the Standards for Reporting Qualitative Research to guide the study design, collection, analysis, and reporting of the data (21) .
Selection of Participants and Setting
The study was conducted at the American College of Emergency Physicians' Scientific Assembly (October 2018, San Diego, CA). We recruited EPs with the explicit goal of achieving a broad representation of experiences, with particular attention paid to recruiting a range of ages, geographic regions, years of experience, and practice settings (including urban, suburban, and rural, and academic vs. community settings). Participants were recruited through posters, social media postings, and direct solicitation. Participants were screened explicitly by the geographic setting in which they practiced to ensure that no region was under-represented. For compensation, participants were offered a $10 gift card for coffee.
Data Collection and Processing
Interviews were collected during five 6-h periods during the conference. Interviews were generally 15 min in duration, without limits for time. Three screening questions were used, ensuring that interviewees practiced > 500 h in the last year, that they worked primarily in an ED setting, and that they had cared for patients requiring naloxone for opioid overdose during that period. The ordering of the first two cases was alternated in half of the interviews to decrease potential case-order confounding. The complete interview guide is available in Appendix A. Interviews were conducted by three attending physician interviewers (J.W.J., B.R., and K.D.M.) who had undergone prior training in qualitative research and who were involved in the writing of the interview prompts. Interviews were recorded and transcribed and underwent a further line-by-line review by the study investigators to ensure accuracy of the transcription.
Primary Data Analysis
A set of a priori codes reflecting potential ethical and practical challenges to treating patients after an opioid overdose within the ED was created by the study investigators based on review of the existing emergency medicine and clinical ethics literature on opioid use, opioid use disorder (OUD), and informed refusal (13, 20, 22, 23) . This process was supplemented by conversations with colleagues with expertise in medical toxicology and addiction psychiatry. These a priori codes reflected broad themes that might guide EPs' reasoning about compliance with observation, such as respect for patients' rights and autonomy, clinical and practical concerns about patients' safety, the longer-term effects of addiction on decision-making, and risks faced by the physicians themselves.
These a priori codes were reviewed by three study investigators (J.W.J., K.D.M., and A.R.D.) and discussed twice daily throughout the conference. Participants were recruited until thematic saturation for the group as a whole was reached, which was defined by consensus as the point at which the most recent set of interviews no longer provided new information.
Using a constant comparative method consistent with modified grounded theory, we employed an iterative coding process whereby we first identified themes and patterns of response thought likely to occur during the interviews before data collection (a priori codes), and later identified additional themes and patterns of response from the interview transcripts (a posteriori codes) (24, 25) . These a posteriori codes reflect more specific concerns within the broader a priori themes. For instance, while two physicians might both express the desire to respect a patients' autonomy, they might differ with respect to whether a patient's potential withdrawal symptoms could compromise their ability to make a truly autonomous decision. Both physicians' statements would fall under the a priori category of respecting autonomy, but would have differing a posteriori codes.
A posteriori codes also are developed from common patterns of responses that the study authors may not have completely anticipated during the development of the study. We anticipated that physicians would be concerned about the potential legal consequences that could stem from involuntarily restraining patients who had capacity, or the malpractice risk of failing to hold patients who lack capacity, and categorized this under the aegis of issues that impacted the physician. However, the legal mechanisms for involuntary commitment can vary from state to state, and predicting which statutes might affect physicians' decision-making would be problematic. Rather than creating an a priori code for every state, we instead allowed the interviewees to guide which standards and procedures of involuntary commitment had a significant impact.
Statements can also reflect multiple codes. In responding to one of the scenarios in which a patient is at higher risk of subsequent decompensation, a physician might state, ''I'm more concerned about this guy because he's on long-acting narcotics. He's at greater risk, and because of that he has to do more to prove that he understands the risks of leaving against advice. I'm willing to treat him with ketorolac or low-dose ketamine if he's having pain, but if I have to, I'll get security to stand outside his room.'' This statement would be coded as applying a principle of proportionality, as well as for clinical concerns about differing opioid half-lives, capacity as primarily understanding risks and benefits, treating pain with nonopioid medications to facilitate cooperation, and a show of force as nonviolent means of de-escalation.
Three investigators (J.W.J., K.D.M., and A.R.D.) developed the codes from line-by-line readings of the text. Specifically, the entire transcribed corpus of interviews was reviewed and coded successively by each reviewer. The list of codes was revised and updated after each round of reviewing. Discrepancies in coding were discussed and resolved by consensus, and all coding was finally reviewed and confirmed by the entire study team.
RESULTS
Characteristics of Study Subjects
Fifty-nine EPs participated in the study. All participants completed the entire interview and all three cases. The study participants represented a variety of ages, years of practice, practice settings, and geographic regions. The full characteristics of the study participants are listed in Table 1 .
Interview Domains and Themes
EPs displayed diversity in their conceptual analysis and management of these cases. These differences were notable in their assessment and management of the clinical aspects of the case, and diverged further in their analysis of ethical features of the case and strategies for resolving the ethical dilemmas. We categorized their differing approaches to scenarios into domains of decision-making capacity assessment, strategies used to encourage compliance with medical recommendations, strategies used to ameliorate risk for patients who refuse to comply, and ethical issues affecting individuals other than the patient. The complete set of codes and the relative frequency with which they appeared are described fully in Table 2 .
Typical Practices and Patient-Centered Clinical Concerns
All physicians interviewed reported that they required patients to remain for some minimum period of observation after they received naloxone, regardless of their clinical status. However, the duration for which physicians estimated that they typically observed patients was highly variable, ranging from 1 h or less (n = 15 [25%]), 2-4 h (n = 29 [48%] ) to up to 6 h (n = 10 [17%]). Several physicians did not wish to give a specific time, but qualified that the duration was primarily dependent on clinical gestalt alone (n = 5 [8%]).
Our case scenarios included larger doses of naloxone than generally recommended for initial resuscitation (7, 8) . We thought that this was necessary in order to realistically convey a scenario in which the patient would be expected to be fully alert and oriented, allowing discussion to focus on the ethical aspects of refusal of care rather than on strategies of naloxone titration. Interestingly, only one respondent noted that the naloxone doses seemed large, while more respondents believed larger doses would be needed, as one EP related, ''4 mg of Narcan? . often it's 10 or 12 before they stir at all.'' While cases 1 and 2 were alternated in order to reduce potential bias from the escalating risk between cases, we thought that case 3, which introduced direct concern for intentional overdose at its conclusion, should remain at the end, as this might bias interviewees to expect an element of suicidality in the other cases. However, many respondents (n = 20 [34%]) discussed screening for suicidality prior to the prompt in the third case, and often did so in the first two cases. Physicians' primary justification for their observation practice was direct experience (n = 36 [60%]), with fewer relying on literature review (n = 14 [23%]), residency training (n = 15 [25%]), or consulting a colleague with fellowship training in toxicology (n = 3 [5%]). Physicians who reported relying on the clinical literature on postnaloxone resuscitation risk to inform their observation practice uniformly reported that they were not aware of existing expedited decision protocols (3, 10) . The majority of physicians interviewed reported that their hospital did not provide institutional guidelines or support for management of these patients (n = 55 [92%]), or formal continuing education on the topic (n = 53 [90%]). The range of clinical practices that EPs reported for postnaloxone observation are detailed in Table 3 .
Ethical Considerations Regarding the Patient Refusing Observation
Throughout the interviews, most physicians described feelings of moral distress, defined as knowing the correct course of action, but being prevented from following it 
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(by institutional or legal constraints) (26) (27) (28) . These feelings arose primarily from conflicts between duties to honor patients' autonomy and to protect patients' health and safety, or from the feeling they were powerless to alter the cycle of opioid use disorder and overdose (Table 4 , quote 1). Many others expressed hopelessness at what they thought were legal strictures preventing them from taking more substantial steps to curb their patients' self-destructive and potentially lethal actions (Table 4 , quote 2).
Assessment and significance of decision-making capacity.
Patients who have capacity to make medical decisions have the right to refuse treatment even if it is lifesustaining, and so our interview was structured to reveal the approaches EPs take to determine capacity in these patients (13, 14) . EPs were aware that capacity assessment is problematic in this patient population, citing threats to decision-making capacity from residual substance intoxication (opioids or co-ingestants), psychiatric comorbidities, or longer-term neurologic effects of OUD. In light of the fact that naloxone has the potential to precipitate withdrawal, several physicians noted that, paradoxically, patients who received more naloxone than was strictly necessary to reverse their overdose might lose the capacity to make rational decisions due to the dysphoric effects of withdrawal. EPs demonstrated wide variability in their approach to assessing decision-making capacity in such patients. Some EPs (n = 17 [29%]) equated capacity merely with the ability to walk and talk (Table 4, (Table 4 , quote 4). Other EPs relied on a gestalt assessment of capacity without reference to a formal standard.
Some EPs used different standards of capacity across different scenarios. While some EPs did not appear cognizant that they were using differing standards of capacity for different patients, others acknowledged doing so. These EPs justified the use of differing standards on the basis of proportionality, in which an increasing potential for harm justifies more stringent standards of capacity (Table 4 , quote 5). In some cases, EPs employed a more stringent standard in the first case, reasoning that they had a greater chance to make a difference in the course of a younger patient naïve to drug use.
EPs also diverged in how a patient's decision-making capacity factored into their response to the patient. Some EPs were willing to allow patients to leave the ED without assessing capacity, or despite determining that the patient lacked capacity (from 14% for a patient with frequent visits to 5% for a patient on multiple long-acting agents). These more permissive EPs tended to focus the on risks of Appealing to physician's concern as a means to convince 7 I try to say, ''I understand you want to leave and that you don't want to be here, I completely appreciate that, but I am trying to do what is best for your medical care.'' And so I try to appeal to their better nature . So it's not like ''I need you to stay,'' but ''I'm so worried about you that if you could stay for a little while it would put my mind at ease.'' Because I find that really works very well. Persuasion, Coercion, and Force
Appealing to physician's concern as a means to convince 8 I put the spin on it like, ''I'm worried about you and I have a responsibility is for your well-being. Help me help you. I need to be able to sleep at night as well, and know that you're going to be ok. So long as we reach this point, you're happy you get to go home, and I'm happy you're not going to go home and die.'' Persuasion, Coercion, and Force Food/comfort as bargaining measure/ drug treatment as ameliorating strategy 9 I do my best to get them to stay for awhile and offer them food and all of those things. And I try to find a referral [to outpatient treatment] for them, but many of them are not interested. Persuasion, Coercion, and Force
Treating with medicine for comfort to gain cooperation 10 I would want to be compassionate and give him some pain control, because if he was on high-dose opiates, and because of the Narcan, he's going to be in withdrawal, so we should do something to treat his pain. I like using verylow-dose ketamine . it seems to do great things for people with pain who are very opiate-tolerant, or who have opiates in their systems. Persuasion, Coercion, and Force
Buprenorphine/MAT as bridging/bargaining measure 11 I had nothing to talk to them about before I had the COWS score, before I was x-waivered. I just wanted to get them out. I had nothing to talk to them about. And now that I got educated on it, I actually have something to talk to them about . so we understand how to treat them better. Persuasion, Coercion, and Force
Show of force as nonviolent means of de-escalation 12 Part of it is how vehement she is that she's leaving. If there's any chance I can deter her, I can have security walk by . but I'm not going to tackle her in the hallway. COWS = Clinical Opiate Withdrawal Scale; EP = emergency physician; MAT = medication for addiction treatment.
Refusal of Observation after Naloxone Resuscitationsedating or restraining the patient to keep them in the ED, concerns about safety of the ED staff, and concerns about diverting resources from other ED patients. Conversely, other EPs showed a readiness to refuse to comply with a patient's wishes, even when they determined a patient demonstrated decision-making capacity (ranging from 17% on the most straightforward case to 46% on the most complex case). EPs taking this more paternalistic approach reasoned that their duty to protect patients superseded a potential temporary infringement of rights, as well as the threat of legal action (Table 4 , quote 6).
Strategies to encourage compliance with observation. EPs suggested a variety of strategies to try to encourage patient compliance with recommendations. Some focused primarily on strategies to form a therapeutic alliance with the patient and to make observation more appealing. These included using specific persuasive techniques to explain the situation in a way that motivated the patient; enlisting the help of the patient's family or friends; and focusing on the patient's comfort, such as providing food, blankets, or medication for ongoing pain or withdrawal symptoms. Many EPs (n = 16 [27%]) combined these appeals and ameliorating measures with offers to help patients find longitudinal treatment for their underlying addiction, including prescribing regimens of medication for addiction treatment (MAT) ( Table 4 , quotes 7-11) (29) .
Other EPs resorted to more deceptive means to achieving compliance, often in tandem with efforts to make patients more comfortable. Most frequently, this included delaying tactics in order to prolong the amount of time a patient could be observed, such as informing patients that they could leave against medical advice only after they had been registered, requiring extensive reading of discharge instructions or other forms prior to being allowed to sign discharge against medical advice forms, or offering food or other comfort measures and then intentionally delivering these items slowly. A few physicians reported engaging in more overt forms of deception, such as informing patients that there existed a state or institutional policy requiring them to stay for observation, while others resorted to coercive maneuvers, such as having security personnel stand by as a show of force even when no actual physical restraints would be used (Table 4 , quote 12).
Some EPs indicated they would resort to force to enforce compliance. A few respondents (n = 10 [17%]) indicated that they would use physical restraints to detain the patient if they attempted to leave before allowing a capacity determination. A similar number (n = 11 [19%] ) reported that they would use chemical restraints to hold patients until observation was complete. Several physicians made recourse to specific state statutes (such as the Marchman Act in Florida) allowing temporary involuntary commitment for individuals endangered by SUDs (29) . This was employed uniformly by these physicians in the second and third case scenarios, where the patients had a history of chronic opioid use, and occasionally during the first scenario, as a means of ensuring compliance with observation.
Ameliorating strategies. In many cases, EPs reluctantly agreed that patients could refuse a period of observation, but said they would make efforts to reduce the risk the patient faced as a result. The most common means for risk reduction was to identify someone reliable that could leave with the patient and monitor them as the naloxone was metabolized (n = 18 [31%]). Another popular strategy (n = 13 [22%]) was to prescribe or give take-home naloxone to patients or family members (in some cases as both a means of harm reduction and a delaying tactic).
Practical considerations. Physicians expressed significant concerns about malpractice risks stemming from both allowing patients to leave (n = 16 [27%]) and keeping them for observation against their will (n = 5 [8%]). While some physicians expressed that having patients sign a discharge against medical advice form provided some measure of protection from litigation, many others noted that litigation (either for failing to observe a patient who refused observation and subsequently overdosed, or for holding a patient against their will) seemed like an inevitable outcome of treating patients with opioid overdoses, given the high likelihood that many patients would use opioids again within a short interval of discharge, even if observed for an appropriate length of time beforehand.
Concerns about violence from patients and the risks they posed to the safety of nursing and physician staff were frequent (n = 17 [29%]). Participants often noted that this stemmed from a lack of adequate security provided by their institution, and that this risk was serious enough to prevent them from providing essential patient care. Likewise, some physicians (n = 7 [12%]) noted that a substantial lack of resources within their ED thwarted their attempts to provide comfortable observation care or to help them with longitudinal resources, such as referral to addiction counseling or MAT.
DISCUSSION
We found that when facing patients who refuse observation and care after an opioid overdose, many EPs experience significant moral distress. They believe that they have a duty to provide necessary patient care but cannot do so without violating their patients' rights, risking serious legal repercussions, or because they do not have the resources to do so safely. Physicians remarked not only how difficult these types of cases are, but also how frequently they encounter them.
Many EPs made reference to the principle of proportionality, requiring patients to meet a more rigorous standard of capacity when the risks of refusing care were higher. However, the absence of clear data about the clinical risks of discharging patients after naloxone makes such judgments difficult. Concerns about the potential legal risks of discharging patients against medical advice or of (temporary) involuntary commitment were common, and many EPs noted that the lack of clinical guidelines or an established standard of practice heightened their concerns for malpractice, even when they provided care that they felt was both clinically and ethically appropriate.
Mirroring the lack of established standards for how long patients should be safely observed were EPs' variable conceptions of autonomy and capacity, which often shifted during the discussions of individual cases. Many EPs equated capacity with the ability to walk and talk. While not being overtly intoxicated is a prerequisite to demonstrating capacity, this standard falls far short of formal definitions of decision-making capacity, and is neither ethically or legally defensible (13, 20) . Having capacity to refuse treatment requires a patient to understand the risks of refusing treatment, appreciate how these risks apply to their situation, reason about their decision relative to their desires and life-goals, and express a choice coherently (14, 30, 31) .
There exists a robust debate within the literature of biomedical ethics and addiction medicine over whether the long-term effects of addiction erode decisionmaking capacity with respect to addiction-related medical problems (32, 33) . The empirical data to support this concern are that individuals with SUDs display measurable deficits in decision-making tasks across a variety of domains but, most saliently, that they have persistently skewed perceptions about the immediate and short-term risks associated with drug use (18, 34) . Notably, there exists conflicting evidence on whether patients who are acutely intoxicated or suffering from complications of SUDs can provide some degree of informed consent; however, this has been studied primarily in the context of opting into research that is supplemental to standard care, rather than opting out of care (16, 35, 36) .
From an ethical standpoint, such deficits in processing information about risks and assigning value to decisional alternatives could be seen as compromising an individual's autonomy, as reflected by the involuntary privileging of an individual's lower-order desires, such as for immediate gratification from substance use, over higher-order desires, such as for maintaining health and achieving life goals (33, 37) . This tension was reflected in the responses of some EPs, who, noting such concerns about the effects of opioids on decision-making, maintained a rigorous standard of capacity, requiring patients to not only be sober and capable of stating the risks of refusing observation, but also to relate the decision to the patient's life goals.
The EPs we interviewed engaged in a variety of strategies to help encourage compliance with observation and to reduce harm. Many of these strategies, such as expressing direct, personal concern for patients' well-being, are rooted in establishing a therapeutic alliance, wellsupported by the addiction medicine literature, and in keeping with the foundational ethical principles of beneficence and respecting autonomy (38) (39) (40) . Likewise, a significant number of interviewees expressed interest in providing MAT in the ED or reported that they had already made this part of their practice. Providing MAT to patients who present post overdose is an appealing intervention from both clinical and ethical standpoints (41, 42) .
Initiating MAT can make patients more comfortable while in the ED, thereby prolonging the amount of time they are willing to be observed and, most importantly, increasing their willingness to participate in subsequent treatment (43, 44) , However, effectively providing MAT is contingent on institutional engagement, which allows treatment started within the ED to be sustained after a patient's index visit. In light of the fact that our interviewees reported a significant lack of institutional assistance for treating post-naloxone patients, this represents a potential hurdle to more widespread adoption of this strategy.
Strategies employing outright deception or forceful coercion directly undermine patients' autonomy and trust in the doctor-patient relationship, and should be confined to those circumstances in which patients are determined to lack capacity and are at serious, immediate risk. While few of the interviewees in our study reported that they would resort directly to paternalistic measures, it is worth noting that a number of states have proposed legislation that may require EPs to do exactly that, such as imposing involuntary 72-h holds within the ED for any patients presenting with an overdose (22, 45) . Notably, these mandates rarely come with the support of additional resources or legal protections for the physicians tasked with carrying them out. These policies underscore the urgent need for physician-led national guidelines for treating the post-naloxone patient that are both evidence-based and ethically sound.
Limitations
The results of this qualitative study are meant to explore the range of ethical and practical dilemmas that EPs face when caring for patients who have received naloxone for opioid overdoses, and to illustrate some of the approaches that they take to address them. The use of simulated scenarios introduces a significant degree of abstraction to our findings, and interviewees' responses may not reflect the immediacy of their everyday practice within the ED. As interviewees knew that the interview was specifically about the ethics of post-naloxone observation, they might also have felt influenced by interviewees to present responses that they thought were more diplomatic than necessarily authentic. Similarly, participants in the study were self-selected, which may bias our results toward those with strong opinions on observation practices (either in favor or opposed), and who are less representative of the specialty as a whole.
While we conducted the study at the largest annual emergency medicine conference, and recruited a pool of interviewees similar in magnitude to previous qualitative studies of EPs, the attendees of the conference themselves may not necessarily be representative of the specialty as a whole (46) . Furthermore, although we recruited subjects from different geographic regions, some areas, such as the Midwest, and groups such as EPs recently out of training, were relatively overrepresented.
The use of a qualitative methodology substantially limits our ability to draw conclusions about the role that factors such as experience or differences in practice setting might play in individuals' responses. We have provided relative counts and percentages of responses for the purpose of illustration, but these cannot be used to carry out statistically meaningful comparisons between groups of interviewees. Correspondingly, providing linkages between interviewees' responses or quotations and information about their practice setting could undermine the confidentiality of their responses.
There are several limitations inherent to the specific case scenarios we used. Our case scenarios were designed to be brief prompts to facilitate the discussion of ethical decision-making rather than detailed clinical diagnosis. While interviewers were instructed to report that patients had generally normal physical examinations except for a mild tachycardia, the lack of additional details may have allowed interviewees to interpret patients as more or less affected by naloxone than intended, which may have influenced their responses.
CONCLUSIONS
Emergency physicians approach the clinical and ethical dilemma of post-naloxone observation in widely divergent ways. The need for further research on the risks of discharge after naloxone is acute. Consensus about strategies for navigating patients' wishes relative to clinical concerns, and how to best integrate care in the ED into the wider mission of combating the opioid epidemic, are needed to help EPs manage these challenging cases so that they can practice compassionately and without the additional burden of moral injury.
